Letter

Pharma and medical education

Some progress in UK psychiatry

BMJ 2008; 337 doi: 10.1136/bmj.a1780 (Published 23 September 2008)
Cite this as: BMJ 2008;337:a1780

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Joanna Moncrieff, senior lecturer1,
  2. Philip Thomas, professor of philosophy, diversity, and mental health2,
  3. Rhodri Huws, consultant in community psychiatry3
  1. 1University College London, London WC1E 6BT
  2. 2International School for Communities, Rights, and Inclusion, University of Central Lancashire, Preston PR1 2HE
  3. 3St George’s Community Health Centre, Sheffield S3 7ND
  1. j.moncrieff{at}ucl.ac.uk

    Moynihan describes the defeated efforts of a group of psychiatrists to free the annual Congress of the Royal Australia and New Zealand College of Psychiatrists from drug company sponsorship.1 These psychiatrists can take heart from the fact that the British Royal College of Psychiatrists conducted its 2008 annual meeting without reliance on any industrial sponsorship. The success of the conference shows that a …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular